Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 9548612, 7 pages
https://doi.org/10.1155/2017/9548612
Research Article

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent

1Heart and Vascular Center, Semmelweis University, Városmajor Utca 68, Budapest 1122, Hungary
2Department of Cardiology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany

Correspondence should be addressed to Zsolt Bagyura; moc.liamg@aruygab

Received 28 November 2016; Revised 19 February 2017; Accepted 23 February 2017; Published 7 March 2017

Academic Editor: Giuseppe Murdaca

Copyright © 2017 Zsolt Bagyura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Ferguson and J. T. Willerson, “Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty,” Texas Heart Institute Journal, vol. 19, no. 1, pp. 54–61, 1992. View at Google Scholar · View at Scopus
  2. A. K. Mitra and D. K. Agrawal, “In stent restenosis: bane of the stent era,” Journal of Clinical Pathology, vol. 59, no. 3, pp. 232–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. K. H. Bønaa, J. Mannsverk, R. Wiseth et al., “Drug-eluting or bare-metal stents for coronary artery disease,” New England Journal of Medicine, vol. 375, no. 13, pp. 1242–1252, 2016. View at Publisher · View at Google Scholar
  4. S. F. Louis and P. Zahradka, “Vascular smooth muscle cell motility: from migration to invasion,” Experimental and Clinical Cardiology, vol. 15, no. 4, pp. e75–e85, 2010. View at Google Scholar · View at Scopus
  5. M. Simons, “VEGF and restenosis: the rest of the story,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 4, pp. 439–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. B. P. Herring, A. M. Hoggatt, C. Burlak, and S. Offermanns, “Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury,” Vascular Cell, vol. 6, no. 1, article 21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Komatsu, M. Ueda, T. Naruko, A. Kojima, and A. E. Becker, “Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses,” Circulation, vol. 98, no. 3, pp. 224–233, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Ahmed, M. K. Hong, R. Mehran et al., “Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting,” Journal of the American College of Cardiology, vol. 36, no. 4, pp. 1186–1193, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Trabattoni, F. Fabbiocchi, P. Montorsi et al., “Angiographic patterns of in-stent restenosis in men and women,” Italian Heart Journal, vol. 6, no. 2, pp. 138–142, 2005. View at Google Scholar · View at Scopus
  10. X. Dai, S. Wiernek, J. P. Evans, and M. S. Runge, “Genetics of coronary artery disease and myocardial infarction,” World Journal of Cardiology, vol. 8, no. 1, pp. 1–23, 2016. View at Publisher · View at Google Scholar
  11. Z. Szelid, Á. Lux, M. Kolossváry et al., “Right ventricular adaptation is associated with the Glu298Asp variant of the NOS3 gene in elite athletes,” PLoS ONE, vol. 10, no. 10, Article ID e0141680, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. W. Verschuren, S. Trompet, I. Postmus et al., “Systematic testing of literature reported genetic variation associated with coronary restenosis: Results of The GENDER Study,” PLOS ONE, vol. 7, no. 8, Article ID e42401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Koch, C. Böttiger, J. Mehilli et al., “Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting,” American Journal of Cardiology, vol. 88, no. 10, pp. 1120–1124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Kastrati, W. Koch, P. B. Berger et al., “Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting,” Journal of the American College of Cardiology, vol. 36, no. 7, pp. 2168–2173, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Keavney, “Outcome following percutaneous coronary intervention: not, so far, in our genes,” Heart, vol. 89, no. 3, pp. 247–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Bagyura, L. Kiss, B. Berta et al., “High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele,” BMC Cardiovascular Disorders, vol. 17, no. 1, p. 4, 2017. View at Publisher · View at Google Scholar
  17. R. Mehran, G. Dangas, A. S. Abizaid et al., “Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome,” Circulation, vol. 100, no. 18, pp. 1872–1878, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Hoffmann and G. S. Mintz, “Coronary in-stent restenosis—predictors, treatment and prevention,” European Heart Journal, vol. 21, no. 21, pp. 1739–1749, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Sanchez-Guerrero, S. R. Jo, B. H. Chong, and L. M. Khachigian, “EGFR and the complexity of receptor crosstalk in the cardiovascular system,” Current Molecular Medicine, vol. 13, no. 1, pp. 3–12, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. M. Schwartz, “Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis,” The Journal of Clinical Investigation, vol. 99, no. 12, pp. 2814–2816, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Wang, S. Ji, and Z. Cheng, “Vascular endothelial growth factor −2578C/A polymorphism and colorectal cancer risk: a meta-analysis,” Journal of Research in Medical Sciences, vol. 20, no. 8, pp. 811–817, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. T.-H. Lin, C.-L. Wang, H.-M. Su et al., “Functional vascular endothelial growth factor gene polymorphisms and diabetes: effect on coronary collaterals in patients with significant coronary artery disease,” Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1688–1693, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Li, Y. Pan, L. Dai, B. Liu, and D. Zhang, “Association of genetic polymorphisms on vascular endothelial growth factor and its receptor genes with susceptibility to coronary heart disease,” Medical Science Monitor, vol. 22, pp. 31–40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Osadnik, J. K. Strzelczyk, R. Reguła et al., “The relationships between polymorphisms in genes encoding the growth factors TGF-β1, PDGFB, EGF, bFGF and VEGF-A and the restenosis process in patients with stable coronary artery disease treated with bare metal stent,” PLOS ONE, vol. 11, no. 3, Article ID e150500, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. L. F. Brown, M. Detmar, K. Claffey et al., “Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine,” EXS, vol. 79, pp. 233–269, 1997. View at Google Scholar · View at Scopus
  26. Q. T. Cui, Y. Li, C. H. Duan, W. Zhang, and X. L. Guo, “Further evidence for the contribution of the vascular endothelial growth factor gene in coronary artery disease susceptibility,” Gene, vol. 521, no. 2, pp. 217–221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Inoue, H. Itoh, M. Ueda et al., “Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis,” Circulation, vol. 98, no. 20, pp. 2108–2116, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Bhardwaj, H. Roy, T. Heikura, and S. Ylä-Herttuala, “VEGF-A, VEGF-D and VEGF-DΔNΔC induced intimal hyperplasia in carotid arteries,” European Journal of Clinical Investigation, vol. 35, no. 11, pp. 669–676, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. K. M. Katsaros, S. P. Kastl, K. A. Krychtiuk et al., “An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents,” EuroIntervention, vol. 10, no. 2, pp. 224–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. C. L. Grosskreutz, B. Anand-Apte, C. Dupláa et al., “Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro,” Microvascular Research, vol. 58, no. 2, pp. 128–136, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. J. H. Bräsen, A. Kivelä, K. Röser et al., “Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 11, pp. 1720–1726, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. C. J. Watson, N. J. A. Webb, M. J. Bottomley, and P. E. C. Brenchley, “Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production,” Cytokine, vol. 12, no. 8, pp. 1232–1235, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Qiu, W. Xiong, H. Liao, and F. Li, “VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis,” Gene, vol. 518, no. 2, pp. 310–315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Sun, Q. Yuan, N. Cao et al., “VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis,” The Scientific World Journal, vol. 2014, Article ID 624573, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. R. Kim and S.-H. Hong, “Association between the polymorphisms of the vascular endothelial growth factor gene and metabolic syndrome,” Biomedical Reports, vol. 3, no. 3, pp. 319–326, 2015. View at Publisher · View at Google Scholar
  36. D. Petrovič, R. Verhovec, M. Globočnik Petrovič, J. Osredkar, and B. Peterlin, “Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes,” Cardiology, vol. 107, no. 4, pp. 291–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Van Der Meer, R. A. De Boer, H. L. White et al., “The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: A MERIT-HF Substudy,” Journal of Cardiac Failure, vol. 11, no. 4, pp. 279–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Moradzadegan, A. Vaisi-Raygani, A. Nikzamir, and Z. Rahimi, “Angiotensin converting enzyme insertion/deletion (I/D) (rs4646994) and Vegf polymorphism (+405G/C; Rs2010963) in type II diabetic patients: association with the risk of coronary artery disease,” JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, vol. 16, no. 3, pp. 672–680, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Nagy, H. Savli, A. Molvarec et al., “Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses,” Clinica Chimica Acta, vol. 389, no. 1-2, pp. 126–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Merlo, J. N. Starčević, S. Mankoč et al., “Vascular endothelial growth factor gene polymorphism (RS2010963) and its receptor, kinase insert domain-containing receptor gene polymorphism (RS2071559), and markers of carotid atherosclerosis in patients with type 2 diabetes mellitus,” Journal of Diabetes Research, vol. 2016, Article ID 1482194, 6 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Iaresko and E. Kolesnikova, “The role of polimorhyms—634 G/C (re 2010963) of VEGF-A gene in the development of hypertensionand obesity in premenopausal women,” Georgian Medical News, vol. 256-257, pp. 33–37, 2016. View at Google Scholar
  42. W. B. Breunis, M. H. Biezeveld, J. Geissler et al., “Vascular endothelial growth factor gene haplotypes in Kawasaki disease,” Arthritis and Rheumatism, vol. 54, no. 5, pp. 1588–1594, 2006. View at Publisher · View at Google Scholar · View at Scopus